Crossmark

ALDH1A inhibition sensitizes colon cancer cells to chemotherapy

Crossref DOI link: https://doi.org/10.1186/s12885-018-4572-6

Published Online: 2018-06-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kozovska, Z. https://orcid.org/0000-0002-3508-0093
Patsalias, A.

Bajzik, V.

Durinikova, E.

Demkova, L.

Jargasova, S.

Smolkova, B.

Plava, J.

Kucerova, L.

Matuskova, M.
License Information

Text and Data Mining valid from 2018-06-15
More Information

Article History

Received: 26 December 2017

Accepted: 31 May 2018

First Online: 15 June 2018

Ethics approval and consent to participate

: Animal experiments were performed in the approved animal facility (license number SK PC 14011) as approved by the institutional ethic committee and by the national competence authority (State Veterinary and Food Administration of the Slovak Republic, registration number Ro 3108/14–221) in compliance with the Directive 2010/63/EU of the European Parliament and the European Council and the Regulation 377/2012 on the protection of animals used for scientific purposes.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.